SEC Comment Letter 0000000000-22-013306 to ObsEva SA (CIK 0001685316)
ObsEva SA (CIK 0001685316)
Date: Dec. 9, 2022 · CIK: 0001685316 · Accession: 0000000000-22-013306
AI Filing Summary & Sentiment
File numbers found in text: 333-268723
Letter
United States securities and exchange commission logo December 9, 2022 Will Brown Chief Financial Officer ObsEva SA Chemin des Aulx, 12 1228 Plan-les-Ouates Geneva, Switzerland Re:ObsEva SA Registration Statement on Form F-3 Filed December 9, 2022 File No. 333-268723 Dear Will Brown: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202)551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Su Lian Lu, Esq.
Show Raw Text
United States securities and exchange commission logo
December 9, 2022
Will Brown
Chief Financial Officer
ObsEva SA
Chemin des Aulx, 12
1228 Plan-les-Ouates
Geneva, Switzerland
Re:ObsEva SA
Registration Statement on Form F-3
Filed December 9, 2022
File No. 333-268723
Dear Will Brown:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202)551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Su Lian Lu, Esq.